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Abstract
Autophagy is a lysosomal degradation pathway that is essential for cell survival and tissue homeostasis. However, limited
information is available about autophagy in aristolochic acid (AA) nephropathy. In this study, we investigated the role of
autophagy and related signaling pathway during progression of AAI-induced injury to renal tubular epithelial cells (NRK52E
cells). The results showed that autophagy in NRK52E cells was detected as early as 3–6 hrs after low dose of AAI (10 mM)
exposure as indicated by an up-regulated expression of LC3-II and Beclin 1 proteins. The appearance of AAI-induced
punctated staining of autophagosome-associated LC3-II upon GFP-LC3 transfection in NRK52E cells provided further
evidence for autophagy. However, cell apoptosis was not detected until 12 hrs after AAI treatment. Blockade of autophagy
with Wortmannin or 3-Methyladenine (two inhibitors of phosphoinositede 3-kinases) or small-interfering RNA knockdown of
Beclin 1 or Atg7 sensitized the tubular cells to apoptosis. Treatment of NRK52E cells with AAI caused a time-dependent
increase in extracellular signal-regulated kinase 1 and 2 (ERK1/2) activity, but not c-Jun N-terminal kinase (JNK) and p38.
Pharmacological inhibition of ERK1/2 phosphorylation with U0126 resulted in a decreased AAI-induced autophagy that was
accompanied by an increased apoptosis. Taken together, our study demonstrated for the first time that autophagy occurred
earlier than apoptosis during AAI-induced tubular epithelial cell injury. Autophagy induced by AAI via ERK1/2 pathway
might attenuate apoptosis, which may provide a protective mechanism for cell survival under AAI-induced pathological
condition.
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Introduction
Autophagy is a cellular process of ‘‘self-digestion’’ through
lysosomal degradation pathway [1,2], which is a major regulated
mechanism for degrading long-lived proteins and organelles. Early
studies confirmed that autophagy was an adaptive responder of
cells to nutrient deprivation, i.e. to ensure minimal housekeeping
functions. In the last decade, a tremendous gain of knowledge on
autophagy has been achieved, showing that cell injury or
accumulation of damaged organelles/membranes, intracellular
inclusions may activate the autophagic pathway [3]. It was
demonstrated cisplatin [4] or cyclosporine A [5] could induce
autophagy in renal tubular epithelial cells, which occurred prior to
apoptosis, and played a protective role during kidney injury.
However, inappropriate activation of autophagy may facilitate cell
death. Previous studies considered type I programmed cell death
(apoptosis), type II (autophagy) and type III (necrosis) represented
the major types of programmed cell death that served to trigger
cell death [6]. The visualization of autophagosomes in dying cells
led to the belief that autophagy is a nonapoptotic form of
programmed cell death. In terms of autophagic death of renal
tissues, it was found that autophagy is another potential
mechanism of nephron loss in obstructive uropathy [7]. These
emerging studies suggested autophagy occurrence was widespread
and important, but its effect on cell fate was controversial.
Aristolochic acids (AAs) are a family of structurally related
nitrophenanthrene carboxylic acids contained in the plant extract
of the aristolochia species such as A. fangchi, A. clematits,a n dA.
manshuriensis [8]. The major components of AAs are AAI and AAII
[9]. AAs were shown to be toxic to renal tubular epithelium cells
[3,10,11]. In terms of pathophysiology of aristolochic acid nephrop-
athy (AAN), apoptosis caused by AAs has been confirmed that leads
to subsequent irreversible proximal tubular atrophy [12,13].
Although autophagy and apoptosis are coordinated processes for
cellfate, the role of autophagy in AAs-induced renal tubular epithelial
cell (RTEC) injury remains unclear. Based on these findings, we first
raised the hypothesis that autophagy may occur and play an
important role in AA-induced renal proximal tubular cell injury.
The complex molecular mechanism of autophagy is responsible
for its complicated and multiple pathways under various
conditions. Of note, these signaling pathways may cross talk and
regulate at different levels in the autophagic cascade [14]. It was
reported that mitogen-activated protein kinases (MAPKs), includ-
ing ERK1/2, p38, and JNK, involved in autophagy induced by
nutrient starvation [15,16]. AAI-induced oxidative DNA damage
associated with ERK1/2 and p38 activation in human promyelo-
PLoS ONE | www.plosone.org 1 January 2012 | Volume 7 | Issue 1 | e30312Figure 1. Autophagy induced by AAI (10 mM) in NRK-52E cells. NRK-52E cells were transiently transfected with GFP-LC3 plasmid. After 0 to
24 hrs of AAI (10 mM) incubation, the cells were fixed and analyzed the formation and distribution of GFP-LC3 puncta by immunofluorescence. A,
Representative images (6600). Arrows indicated GFP-LC3 puncta (green). Nuclei (blue) were stained by Hoechst33342. B, Percentage of cells with
GFP-LC3 puncta. C, Western blot showed an increase in Beclin 1 and LC3-II at early stage of AAI incubation. D, Densitometric analysis of LC3-II in
Fig. 1C. The protein expression level of control (0 hr) group was arbitrarily set as 1 in each blot, and the signals of other conditions in the same blot
were normalized with the control to indicate their protein expression level. E, Western blot showed an continue increase in LC3-II with the lysosomal
inhibitors E64d (10 mg/ml)+Pepstatin A (10 mg/ml) after AAI incubation. F, Densitometric analysis of LC3-II in Fig. 1E. B, D and F were expressed as
means6SEM of three independent experiments. *and**denote p,0.05 and p,0.001, respectively, when compared to control condition.
doi:10.1371/journal.pone.0030312.g001
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mechanisms regulating AAs-induced autophagy are not defined.
In this study, we investigated the role of autophagy and related
signaling pathway during progression of AAI-induced injury to
renal tubular epithelial cells (NRK52E cells). We provided
evidence that autophagy occurred earlier than apoptosis during
AAI-induced tubular epithelial cell injury. Autophagy induced by
AAI via ERK1/2 pathway could attenuate apoptosis, which may
provide a protective mechanism for cell survival under AAI-
induced pathological condition.
Materials and Methods
Antibodies and reagents
Dulbecco’s modified Eagle’s medium/F12 (DMEM/F12) and
fetal bovine serum (FBS) were purchased from Gibco BRL
(GIBCO-BRL, Grand Island, NY). AAI was purchased from
National Institute for the Control of Pharmaceutical and
Biological Products (Beijing, China) and was prepared as a stock
solution of 8.3 mg/ml in 100% dimethyl sulfoxide (DMSO) for
cell culture. Anti-LC3 was purchased from Novus Biologicals,
LLC (Novus Biologicals, Littleton, CO, USA) and anti-Beclin 1,
anti-Atg7 from Abcam.Ltd (Abcam, Cambridge, UK). Anti-
cleaved caspase3, anti-b-Actin, anti-phospho-P44/42 MAP Ki-
nase, anti-P44/42 MAP Kinase, anti-SAPK/JNK, anti-phospho-
SAPK/JNK, anti-p38MAP Kinase and anti-phospho-p38 MAP
Kinase were from Cell Signaling Technology.Inc (CST, Danvers,
Mass, USA). All secondary antibodies from Santa Cruz Biotech-
nology,H inc. (Santa Cruz, California, USA) Lipofectamine 2000
was from Invitrogen Life Techonologies (Invitrogen, Carlsbad,
CA). Wortmannin, E64d, Pepstatin A, 3-Methyladenine (3-MA),
Annexin V-FTIC Apoptosis Detection Kit and U0126 were from
Sigma-Aldrich Co. (Sigma, St Louis, MO, USA).
Cell culture and AAI treatment
Normal rat renal tubular epithelial cells (TECs) line, NRK52E,
was originally obtained from ATCC, USA and maintained in
DMEM/F12 containing 10% FBS at 37uCw i t h5 %C O 2. The cells
Figure 2. Apoptosis induced by AAI (10 mM) in NRK-52E cells. A, Representative annexinV/PI flow cytometry analysis at different AAI
incubation time. The percentage of early apoptotic cells was identified with Annexin V+PI2 (R4) and late apoptotic and necrotic cells was identified
with AnnexinV+PI+ (R2). B, Quantitative analysis of AnnexinV+PI2 and AnnexinV+PI+ NRK52E cells by flow cytometry. C, Western blot showed an
increase in cleaved Caspase-3 after AAI incubation from 12 hrs to 24 hrs, while cleaved Caspase-3 didn’t increase (0,24 hrs) without AAI incubation.
D, Densitometric analysis of cleaved Caspase-3 in Fig. 2C. B and D: Data was expressed as means6SEM of three independent experiments.
*and**denote p,0.05 and p,0.001, respectively, when compared to control condition.
doi:10.1371/journal.pone.0030312.g002
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6 cells per dish and
subconfluent cells were used for the experiments. The cells were
incubated either without or with AAI at various concentrations for
different time period as indicated as follow. In preliminary studies,
the suitable concentration and optimum exposure time of AAI were
determined as 10 mM for 0 to 24 hrs. To observe the effects of
inhibitors, cells were treated with the inhibitor Wortmannin (20 nM)
[18], E64d(10 mg/ml)+Pepstatin A (10 mg/ml), 3 MA(5 mM) or
U0126 (5 mM) [19] for 15 min, respectively, before addition of AAI
according to the results of our preliminary tests.
Transient transfection
The GFP-LC3 fusion plasmid was kindly provided by Professor
Zhu Xiaofeng. NRK52E cells were plated at a density of 2610
5 on
a coverslip and cultured up to 60% confluence. Transfection was
carried out with Lipofectamine 2000 as manufacturer’s recom-
mendation and 2 mg/ml GFP-LC3 plasmid DNA in each dish was
used. After incubation in Opti-MEM medium for 5–6 hrs, the
cells were incubated in DMEM/F12 containing 10% FBS
medium again. When cells reached 90% confluence, AAI was
added into culture medium. The transfection efficiency for
NRK52E cells was 20%, approximately.
RNA interference
As we known, Beclin 1 and its binding partner class III
phosphoinositide 3-kinase (PI3K), also named Vps34, are required
for the initiation of the formation of autophagosome during
autophagy. The following sequence was used for short interfering
RNA (siRNA) against Beclin 1: sense strand 59-GAUUGAAGA-
CACAGGAGGC-3 [20]. For siRNA against Atg7, the following
sequence was used: 59-GCAUCAUCUUUGAAGUGAA-39 (Sig-
ma). For a control siRNA, the following sequences were used:
sense strand 59-UUC UCC GAA CGU GUC ACG UTT-39, anti-
sense 59-ACG UGA CAC GUU CGG AGA ATT-39. siRNA was
transiently transfected using Lipofectamine 2000.
Cell lysis, SDS-PAGE and western blotting
Cells were lysed on ice for 15 min in 16RIPA lysis buffer.
Protein concentration was measured using the Bradford assay.
The amount of protein was approximately 30,60 mg (concentra-
tion measured by Bradford method: 1.5,3 mg/ml) per sample.
Equal amounts of cell extracts were boiled for 5 min in the
presence of 1% 2-mercaptoethanol and 2% sodium dodecyl sulfate
(SDS). Samples were electrophoresed on 15% SDS-poly-acrylam-
ide gels, and then transferred to polyvinylidene difluoride (PVDF)
membrane. Membranes were blocked with 5% (wt/vol) milk
proteins/Tris-buffered saline and incubated overnight at 4uC with
the primary antibody: rabbit anti-LC3 (2 mg/ml), rabbit anti-
Beclin 1 (1 mg/ml), rabbit anti-Atg7 (1 mg/ml), rabbit anti-cleaved
caspase 3 (2 mg/ml), anti-phospho-P44/42 MAP Kinase (2 mg/
ml), anti-P44/42 MAP Kinase (2 mg/ml), anti-SAPK/JNK (2 mg/
ml), anti-phospho-SAPK/JNK (2 mg/ml), anti-p38MAP Kinase
(2 mg/ml) and anti-phospho-p38 MAP Kinase (2 mg/ml). Bound
antibodies (dilution:1:2000) were detected with appropriate
secondary antibodies and enhanced chemiluminescence. Same
blots were probed with anti-b-Actin to monitor protein loading
and transferring. A densitometric quantification of western blot
signal intensity of membranes was performed.
Autophagy assays
Autophagy was examined by analyzing the formation of
fluorescent puncta of autophagosomes in GFP-LC3 transfected
cells and immunoblot analysis of LC3-II and Beclin 1, another
essential autophagy related protein. In fluorescence microscopy
experiments, NRK52E cells were transiently transfected with
GFP-LC3 plasmid and treated with AAI as described above. After
treatment, the cells were fixed with 4% paraformaldehyde.
Autophagy was evaluated by examining the punctate forms (type
II) of the autophagy marker LC3 based on GFP-LC3. Quantita-
tion of autophagy was done based on the percentage of GFP-LC3-
positive autophagic vacuoles or cells with LC3 punctate dots.
Twenty fields of 6600 magnification with 20 to 30 GFP-labeled
green cells per field were counted in each condition [21].
Cell apoptosis determination
All cells under various experimental conditions were harvested
with PBS containing 0.05 trypsin and rinsed with PBS. Apoptosis
cells were quantitated by staining with Annexin V-FITC and
Propidium iodide (PI), and then measured with flow cytometry
(FCM) according to the protocol of the AnnexinV-FITC Apoptosis
Detection Kit. For morphology of apoptotic cells, treated cells on
the coverslips were fixed with 4% paraformaldehyde (PFA) and
stained with 2 mg/ml Hoechst 33342. Nuclear morphology was
examined by fluorescence microscopy. Immunoblot assay was
used for cleaved-caspase3 analysis.
Statistics
Qualitative data was representative of at least three experiments
and was expressed as means 6SEM. Statistical analysis was
conducted using the GraphPad Prism software. Statistical
differences in multiple groups were determined by multiple
comparisons with analysis of variance followed by Tukey’s post-
tests. Statistical differences between two groups were determined
by two-tailed unpaired Student’s t-test. P,0.05 was considered
significant difference.
Results
Autophagy was induced in NRK52E cells in response to
AAI treatment
A low concentration of AAI (10 mM) was selected according to
the results of MTT assay (data not shown) and the autophagy
occurrence after AAI exposure in NRK52E cells was observed by
detecting expression of GFP-LC3. Following AAI exposure, the
transfected cells showed distributed puncta at 3 hrs which last later
periods, while control transfected cells without AAI treatment
showed a diffuse distribution of green fluorescence (Fig. 1A). Cell
counting showed that 6 to 12 hrs of AAI exposure increased GFP-
Figure 3. Inhibition of autophagy by Wortmannin and 3-MA increased apoptosis during AAI incubation of NRK52E cells. NRK52E cells
were incubated for 12 hrs in the absence (DMSO control), or presence of AAI (10 mM), Wortmannin (20 nM), 3 MA (5 mM) or AAI plus Wortmannin,
AAI plus 3 MA. Wortmannin and 3-MA blockaded the autophagy and increased apoptosis induced by AAI. A and B: Western analysis using antibodies
against LC3-II or b-Action. C and D: Densitometric analysis of LC3II in Fig. 3A and 3B. NRK52E cells were transiently transfected with GFP-LC3 plasmid,
then were subjected to the same conditions as described. E, Representative images (6800). Arrows indicated GFP-LC3 puncta (green). Nuclei (blue)
were stained by Hoechst33342. F, Graphs represent quantitation analysis of the percentage of cells with GFP-LC3 positive autophagosomes. G,
Representative annexinV/PI flow cytometry analysis of NRK52E cells. H, Graphs represented quantitation of analysis of AnnexinV+PI2 and
AnnexinV+PI+ NRK52E cells by flow cytometry. C, D, F and H: Data was expressed as means6SEM of three independent experiments. *and** denote
p,0.05 and p,0.001, respectively, when compared to control condition.
#denote p,0.05,compared to AAI group.
doi:10.1371/journal.pone.0030312.g003
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LC3-II formation was also tested by western blot analysis. AAI
incubation induced a time-dependent accumulation of Beclin 1
and LC3-II in NRK52E cells, which appeared at 3 hrs and
increased dramatically at 12 hrs, then decreased slightly thereafter
(Fig. 1C and 1D). E64d and pepstatin A could inhibit degradation
of LC3-II partially. The Fig. 1E and 1F showed the lysosomal
inhibitors significantly increased LC3-II accumulation of
NRK52E cells during incubation of AAI at each time point.
These findings indicated that AAI didn’t block autophagic flux,
but induced the autophagic activity.
Apoptosis followed tubular cell autophagy in response
to AAI treatment
Cell apoptosis at the same condition described above was
measured by FCM. As shown in Fig. 2A, during early stage of AAI
treatment (3–6 hrs), most cells were normal and dynamic.
Apoptotic cells were not induced until 12 hrs and increased
thereafter in a time-dependent way (Fig. 2A and 2B). At 12 h,
approximate 15% cells were early apoptotic cells (Fig. 2A, Region
4), while small amount (5.3861.29%) of late apoptotic cells
(Fig. 2A, Region 2) was detected. After 12 hrs of AAI treatment,
early apoptotic and normal cells were dying gradually. Over 25%
late apoptotic and necrotic cells occurred at 24 hrs. Immunoblot
analysis results proved that AAI did not induce significant up-
regulated expression of cleaved-caspase 3 (17 kDa) in NRK52E
cells until 12 hrs of incubation (Fig. 2C).
Inhibition of AAI-induced autophagy with Wortmannin
increased apoptosis in NRK52E Cells
To investigate the effect of autophagy on cell apoptosis,
Wortmannin and 3-Methyladenine (3-MA), two types of potent
pharmacological inhibitors on autophagy, were used to suppress
the autophagy induced by AAI. Our preliminary tests demon-
strated that 15 min pretreatment with 20 nM Wortmannin or
5 mM 3-MA could block autophagy in NRK52E cells without
significant cytotoxicity. As shown in figure 3A and 3B,
Wortmannin or 3-MA pretreatment reduced the accumulation
of LC3-II (Fig. 3A–D) and formation of GFP-LC3 puncta (Fig. 3E
and 3F, as arrow indication). The effects of Wortmannin or 3-MA
on apoptosis after AAI treatment were shown in figure 3G and
3H. Wortmannin or 3-MA itself scarcely induced cell apoptosis
and cell death, but significantly increased apoptosis at 12 hrs after
AAI exposure (AAI group: 18.8%; AAI plus Wortmannin group:
28.1%; AAI plus 3-MA:37.2%). These results suggested that
suppression of autophagy by Wortmannin or 3-MA could increase
AAI-induced injury in renal tubular epithelium cells.
Short interfering RNAs (siRNA) against Beclin 1
accelerated AAI-induced apoptotic death in NRK52E cells
To further confirm the role of autophagy on cell fate, the effects
of Beclin 1 and Atg7 knockdown on AAI-induced apoptosis in
NRK52E cells were examined. NRK52E cells were transfected
with siRNA of Beclin 1, siRNA of Atg7 or a negative control
siRNA, respectively. The cells were then treated with AAI (10 mM)
from 0 hr to 24 hrs. Compared with negative control siRNA
interference, Beclin 1 siRNA or Atg7 siRNA interference
remarkably abrogated the AAI-induced autophagy, which was
obvious at 12 hrs (Fig. 4A–F). AAI-induced cell apoptosis and
death were evaluated by Annexin V and PI assay as well as
Hoechst33342 staining. As shown in figure 4G and 4H, there
wasn’t significant difference in cell apoptosis among negative
control siRNA group, Beclin 1 siRNA group and Atg7 siRNA
group under full culture condition without AAI treatment. The
transfected cells were then subjected to 12 hrs of AAI treatment.
Compared with the negative control siRNA group, knockdown of
Beclin 1 or Atg7 increased cell apoptosis significantly after AAI
treatment, especially for late apoptotic and necrotic cells (Fig. 4G
and 4H). The morphology study of apoptotic cells by
Hoechst33342 offered further evidence (Fig. 4I). In negative
control siRNA group, few apoptotic cells were detected morpho-
logically when cells were exposure on AAI for 6 hrs, while several
clusters of apoptotic cells were observed in Atg7 siRNA and Beclin
1 siRNA group at the same time point (Fig. 4I). Compared with
negative control siRNA group, more cells both in Beclin 1 siRNA
group and Atg7 siRNA group developed to apoptotic death at
12 hrs, which exhibited as some adherent apoptotic cells exfoliated
from coverslips and couldn’t be fixed and detected by morphology.
These results provided evidence that autophagy related gene
siRNA interference could inhibit LC3-II formation and accelerate
AAI induced cell death.
AAI induced autophagy via activation ERK1/2 pathway
Under the same incubation condition of AAI, phosphorylation
level of mitogen-activated protein kinases (MAPKs), including
ERK1/2, p38, and JNK proteins were detected by western blot
analysis. AAI induced a significantly activation of ERK1 and
ERK2 in a time-dependent way which began at 3 hrs and peaked
at 18 hrs (Fig. 5A and 5C). However, 10 mM AAI exposure had
little effect on the activation JNK and p38 in NRK52E cells
(Fig. 5A). To further investigate the effect of ERK1/2 activation
on autophagy, ERK1/2 was blocked with U0126 (5 mM), an
ERK1/2 inhibitor. U0126 itself didn’t alter accumulation of LC3-
II protein, but attenuated AAI-induced LC3-II protein accumu-
lation partially (Fig. 5B and 5E). The immunofluorescence offered
another evidence, in which pre-treatment with U0126 resulted in a
decreased autophagosome formation (Fig. 5F and 5G). These
results demonstrated that ERK1/2 signaling pathway involved in
AAI induced-autophagy. At last, the effect of U0126 on cell
apoptosis induced by AAI was detected. U0126 itself didn’t affect
cell apoptosis, but significantly increased AAI-induced apoptosis in
NRK52E cells (Fig. 5H and 5I).
Discussion
Despite some autophagy research were done in other renal
diseases [5,21,22], information about autophagy in AAs-induced
Figure 4. Increased apoptotic and necrotic cells after knockdown of Beclin 1 or Atg7 in NRK52E cells during AAI incubation. NRK52E
cells were transiently transfected with negative control siRNA, Beclin 1 siRNA and Atg7 siRNA. The transfected cells were then treated with AAI
(10 mM) for 0 to 24 hrs. A, Representative immunoblot images of Beclin 1 and LC3-II. B, Representative immunoblot images of Atg7 and LC3-II. C,
Densitometric analysis of Beclin 1 in Fig. 4A. D, Densitometric analysis of Atg7 in Fig. 4B. E, Densitometric analysis of LC3II of Fig. 4A. F, Densitometric
analysis of LC3II in Fig. 4B. G, Representative annexinV/PI flow cytometry analysis of negative control siRNA, Beclin 1 siRNA and Atg7 siRNA
transfected cells with or without AAI treatment for 12 hrs. H, Quantitative analysis of AnnexinV+PI2 and AnnexinV+PI+ NRK52E cells by flow
cytometry. I, Typically morphological apoptotic cells images at different time (6600). C,D,E,F and H:Data was expressed as means6SEM of three
independent experiments. *and** denote p,0.05 and p,0.001, respectively, when compared to control siRNA without AAI treatment, respectively.
# denote p,0.05, when compared to control siRNA with AAI treatment.
doi:10.1371/journal.pone.0030312.g004
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Representative immunoblot images of p-ERK1/2, ERK1/2, JNK1/2, p-JNK1/2, p–p38 and p38 proteins. ERK1/2 pathway was activated at early stage, but
not JNK and P38. U0126 inhibited activation of ERK1/2 pathway and accumulation of LC3II induced by AAI. NRK52E cells were incubated for 12 hrs in
the absence (DMSO control), or presence of AAI (10 mM), U0126 (5 mM) or AAI plus U0126. B, Representative immunoblot images of p-ERK1/2, ERK1/2,
Beclin 1 and LC3II proteins. C, Densitometric analysis of p-ERK1/2 in Fig. 5A. D, Densitometric analysis of p-ERK1/2 in Fig. 5B. E, Densitometric analysis
of LC3II in Fig. 5B. F, Representative images (6800). Arrowheads indicate GFP-LC3 puncta (green). Nuclei (blue) were stained by Hoechst33342. G,
Graphs represent quantitation analysis of the percentage of cells with GFP-LC3 positive autophagosomes. U0126 increased cell apoptosis induced by
AAI. H, Representative annexinV/PI flow cytometry analysis of cells from DMSO control, AAI, U0126 and AAI plus U0126 groups. I, Quantitative
analysis of AnnexinV+PI2 and AnnexinV+PI+ NRK52E cells by flow cytometry. C,D,E,G and I: Data was expressed as means6SEM of three
independent experiments. *and** denote p,0.05 and p,0.001, respectively, when compared to control condition.
#denote p,0.05,compared to AAI
group.
doi:10.1371/journal.pone.0030312.g005
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autophagy during AAI-induced renal tubular epithelium cell
injury. We demonstrated for the first time that low dose of AAI
(10 mM) induced autophagy in NRK52E cells as early as 3 hrs,
and maintained at high level for 12 hrs, which was indicated by
punctuate GFP-LC3 localization and LC3-II formation. It was
reported that an increase in autophagosomes, the morphologic
hallmark of autophagy, in cultured renal tubular cells under
hypoxic condition as well as cisplatin induced injury. Our results
accorded with these studies concerning renal tubular injury and
autophagy. Besides, we confirmed that AAI didn’t block
autophagic flux, but induced autophagic activity by observing
the accumulation of LC3 II with or without lysosomal protease
inhibitors. We also found AAI induced scarce apoptotic cells until
12 hr. These results clearly confirmed that AAI-induced autoph-
agy occurred prior to apoptosis in proximal tubules.
Whether autophagy enhances or diminishes the apoptotic
response is a debated issue. Indeed, investigating the interplay
between autophagy and apoptosis is beneficial if the autophagy
pathway is to be targeted effectively in the treatment of disease.
Under the AAs induced-injury, renal tubular epithelial apoptosis is
a mainly pathophysiological mechanism, which leads to tubular
epithelial cell deletion and tubular atrophy [11,23]. The next
question we addressed was whether this induction of autophagy
observed in the AAI induced-cell injury was specific to affect the
fate of cells. We demonstrated that inhibition of autophagy with
Wortmannin or 3-MA, two effective autophagy inhibitors,
significantly increased AAI induced apoptosis rate, whereas
Wortmannin and 3-MA themselves didn’t affect cell apoptosis.
Beclin 1 and Atg7 are autophagy-related genes which are two type
key genes for formation of autophagy [24,25]. To further confirm
the effect of autophagy, small-interfering RNA knockdown of
Beclin 1 or Atg7 was used to block autophagy in cultured
NRK52E cells, respectively. It was shown that down-regulation of
Beclin 1 or Atg7 decreased AAI-induced LC3-II formation.
Compared with negative control siRNA group, both Beclin 1
siRNA and Atg7 siRNA enhanced apoptosis during AAI
incubation as indicated by apoptotic cells detected as early as
6 hrs and more apoptotic cell death detected at 12 hrs after AAI
treatment. Taken together, these data support that autophagy
protect renal tubular cells from apoptosis under AAI toxicity and
play an essential prosurvival role in AA-induced renal tubular cell
injury.
Wang, et al. reported the AMPK-MEK/ERK-TSC-mTOR
pathway regulation of Beclin 1 represented different thresholds
responsible for a protective or destructive autophagy [26].
Sivaprasad et al. confirmed that inhibition of ERK1/2 in MCF-7
cells resulted in decreased autophagy in response to TNF,
accompanied with increasing sensitivity of cell death [27]. In
consistent with these results, we demonstrated in this study that
AAI induced autophagy in NRK52E cells via the ERK1/2
pathway, which indicated by an upregulation of pERK1/2 protein
expression at early stage and an attenuated accumulation of LC3-
II by inhibitor of ERK1/2. Although JNK and p38 played a
critical role in autophagy induced by cellular starvation and cell
swelling [28,29], our study couldn’t observe the activation of JNK
and p38 during AAI induced-cell injury.
In summary, our study demonstrated for the first time that
autophagy occurred earlier than apoptosis during AAI-induced
tubular epithelial cell injury. Autophagy induced by AAI via
ERK1/2 pathway might attenuate apoptosis, which may provide a
protective mechanism for cell survival under AAI-induced
pathological condition. More studies have to be performed to
understand how autophagic and apoptotic responses by AAI
orchestrate to contribute to the AAN.
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